Report Overview
Report Summary
Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Traveler's Diarrhea Therapeutics market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Traveler's Diarrhea Therapeutics market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
Key Research Highlights: Market Drivers
The Traveler's Diarrhea Therapeutics market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Traveler's Diarrhea Therapeutics products across developed and developing countries of the world.
Key Research Highlights: Market Restrains
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Traveler's Diarrhea Therapeutics products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Traveler's Diarrhea Therapeutics market.
To learn more about this report
Key Research Highlights: Trends
Increasing research and development spending on Traveler's Diarrhea Therapeutics development has been the leading industry trend of Traveler's Diarrhea Therapeutics market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
Global Traveler's Diarrhea Therapeutics Market Size, 2018-2028 (USD MILLION)
To learn more about this report
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Anti-Motility Agents,Bismuth Subsalicylate (Pepto-Bismol),Antibiotics, Other |
| By Application Outlook |
Adult Traveler's Diarrhea,Children Traveler's Diarrhea, Other |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
GSK,Salix Pharmaceuticals,Chiesi Farmaceutici,Cosmo Pharmaceuticals,Nippon Shinyaku,Prokarium Limited,Scandinavian Biopharma,Sigmoid Pharma |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Market Players
- GSK
- Salix Pharmaceuticals
- Chiesi Farmaceutici
- Cosmo Pharmaceuticals
- Nippon Shinyaku
- Prokarium Limited
- Scandinavian Biopharma
- Sigmoid Pharma
Traveler's Diarrhea Therapeutics Market, By Type
- Anti-Motility Agents
- Bismuth Subsalicylate (Pepto-Bismol)
- Antibiotics
- Other
Traveler's Diarrhea Therapeutics Market, By Application
- Adult Traveler's Diarrhea
- Children Traveler's Diarrhea
- Other
Key Benefits To The Stake Holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Table Of Contents
Table Of Contents
Table of Contents
Global Traveler's Diarrhea Therapeutics Market Report 2020, Forecast to 2027
1 Scope of the Study
1.1 Traveler's Diarrhea Therapeutics Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives
2 Traveler's Diarrhea Therapeutics Industry Overview
2.1 Global Traveler's Diarrhea Therapeutics Market Size (Million USD) Comparison by Regions (2020-2027)
2.1.1 Traveler's Diarrhea Therapeutics Global Import Market Analysis
2.1.2 Traveler's Diarrhea Therapeutics Global Export Market Analysis
2.1.3 Traveler's Diarrhea Therapeutics Global Main Region Market Analysis
2.2 Market Analysis by Type
2.2.1 Anti-Motility Agents
2.2.2 Bismuth Subsalicylate (Pepto-Bismol)
2.2.3 Antibiotics
2.3.2 Children Traveler's Diarrhea
2.4.2 Global Traveler's Diarrhea Therapeutics Revenue and Market Share by Manufacturer (2018-2020)
2.4.3 Global Traveler's Diarrhea Therapeutics Industry Concentration Ratio (CR5 and HHI)
2.4.4 Top 5 Traveler's Diarrhea Therapeutics Manufacturer Market Share
2.4.5 Top 10 Traveler's Diarrhea Therapeutics Manufacturer Market Share
2.4.6 Date of Key Manufacturers Enter into Traveler's Diarrhea Therapeutics Market
2.4.7 Key Manufacturers Traveler's Diarrhea Therapeutics Product Offered
2.4.8 Mergers & Acquisitions Planning
2.5 Traveler's Diarrhea Therapeutics Historical Development Overview
2.6 Market Dynamics
2.6.1 Market Opportunities
2.6.2 Market Risk
2.6.3 Market Driving Force
2.6.4 Porter's Five Forces Analysis
3 Upstream and Downstream Market Analysis
3.1 Upstream Analysis
3.1.1 Macro Analysis of Upstream Markets
3.1.2 Key Players in Upstream Markets
3.1.3 Upstream Market Trend Analysis
3.1.4 Traveler's Diarrhea Therapeutics Manufacturing Cost Analysis
3.2 Downstream Market Analysis
3.2.1 Macro Analysis of Down Markets
3.2.2 Key Players in Down Markets
3.2.3 Downstream Market Trend Analysis
3.2.4 Sales Channel, Distributors, Traders and Dealers
4 Global Traveler's Diarrhea Therapeutics Market Size Categorized by Regions
4.1 Global Traveler's Diarrhea Therapeutics Revenue, Sales and Market Share by Regions
4.1.1 Global Traveler's Diarrhea Therapeutics Sales and Market Share by Regions (2015-2020)
4.1.2 Global Traveler's Diarrhea Therapeutics Revenue and Market Share by Regions (2015-2020)
4.2 Europe Traveler's Diarrhea Therapeutics Sales and Growth Rate (2015-2020)
4.3 APAC Traveler's Diarrhea Therapeutics Sales and Growth Rate (2015-2020)
4.4 North America Traveler's Diarrhea Therapeutics Sales and Growth Rate (2015-2020)
4.5 South America Traveler's Diarrhea Therapeutics Sales and Growth Rate (2015-2020)
4.6 Middle East & Africa Traveler's Diarrhea Therapeutics Sales and Growth Rate (2015-2020)
5 Europe Traveler's Diarrhea Therapeutics Market Size Categorized by Countries
5.1 Europe Traveler's Diarrhea Therapeutics Sales, Revenue and Market Share by Countries
5.1.1 Europe Traveler's Diarrhea Therapeutics Sales by Countries (2015-2020)
5.1.2 Europe Traveler's Diarrhea Therapeutics Revenue by Countries (2015-2020)
5.1.3 Germany Traveler's Diarrhea Therapeutics Sales and Growth Rate (2015-2020)
5.1.4 UK Traveler's Diarrhea Therapeutics Sales and Growth Rate (2015-2020)
5.1.5 France Traveler's Diarrhea Therapeutics Sales and Growth Rate (2015-2020)
5.1.6 Russia Traveler's Diarrhea Therapeutics Sales and Growth Rate (2015-2020)
5.1.7 Italy Traveler's Diarrhea Therapeutics Sales and Growth Rate (2015-2020)
5.1.8 Spain Traveler's Diarrhea Therapeutics Sales and Growth Rate (2015-2020)
5.2 Europe Traveler's Diarrhea Therapeutics Revenue (Value) by Manufacturers (2018-2020)
5.3 Europe Traveler's Diarrhea Therapeutics Sales, Revenue and Market Share by Type (2015-2020)
5.3.1 Europe Traveler's Diarrhea Therapeutics Sales Market Share by Type (2015-2020)
5.3.2 Europe Traveler's Diarrhea Therapeutics Revenue and Revenue Share by Type (2015-2020)
5.4 Europe Traveler's Diarrhea Therapeutics Sales Market Share by Application (2015-2020)
6 Asia-Pacific Traveler's Diarrhea Therapeutics Market Size Categorized by Countries
6.1 Asia-Pacific Traveler's Diarrhea Therapeutics Sales, Revenue and Market Share by Countries
6.1.1 Asia-Pacific Traveler's Diarrhea Therapeutics Sales by Countries (2015-2020)
6.1.2 Asia-Pacific Traveler's Diarrhea Therapeutics Revenue by Countries (2015-2020)
6.1.3 China Traveler's Diarrhea Therapeutics Sales and Growth Rate (2015-2020)
6.1.4 Japan Traveler's Diarrhea Therapeutics Sales and Growth Rate (2015-2020)
6.1.5 Korea Traveler's Diarrhea Therapeutics Sales and Growth Rate (2015-2020)
6.1.6 India Traveler's Diarrhea Therapeutics Sales and Growth Rate (2015-2020)
6.1.7 Southeast Asia Traveler's Diarrhea Therapeutics Sales and Growth Rate (2015-2020)
6.1.8 Australia Traveler's Diarrhea Therapeutics Sales and Growth Rate (2015-2020)
6.2 Asia-Pacific Traveler's Diarrhea Therapeutics Sales and Revenue (Value) by Manufacturers (2018-2020)
6.3 Asia-Pacific Traveler's Diarrhea Therapeutics Sales, Revenue and Market Share by Type (2015-2020)
6.3.1 Asia-Pacific Traveler's Diarrhea Therapeutics Sales Market Share by Type (2015-2020)
6.3.2 Asia-Pacific Traveler's Diarrhea Therapeutics Revenue and Revenue Share by Type (2015-2020)
6.4 Asia-Pacific Traveler's Diarrhea Therapeutics Sales and Market Share by Application (2015-2020)
7 North America Traveler's Diarrhea Therapeutics Market Size Categorized by Countries
7.1 North America Traveler's Diarrhea Therapeutics Sales, Revenue and Market Share by Countries
7.1.1 North America Traveler's Diarrhea Therapeutics Sales by Countries (2015-2020)
7.1.2 North America Traveler's Diarrhea Therapeutics Revenue by Countries (2015-2020)
7.1.3 United States Traveler's Diarrhea Therapeutics Sales and Growth Rate (2015-2020)
7.1.4 Canada Traveler's Diarrhea Therapeutics Sales and Growth Rate (2015-2020)
7.1.5 Mexico Traveler's Diarrhea Therapeutics Sales and Growth Rate (2015-2020)
7.2 North America Traveler's Diarrhea Therapeutics Revenue (Value) by Manufacturers (2018-2020)
7.3 North America Traveler's Diarrhea Therapeutics Sales, Revenue and Market Share by Type (2015-2020)
7.3.1 North America Traveler's Diarrhea Therapeutics Sales Market Share by Type (2015-2020)
7.3.2 North America Traveler's Diarrhea Therapeutics Revenue and Revenue Share by Type (2015-2020)
7.4 North America Traveler's Diarrhea Therapeutics Sales Market Share by Application (2015-2020)
8 South America Traveler's Diarrhea Therapeutics Market Size Categorized by Countries
8.1 South America Traveler's Diarrhea Therapeutics Sales, Revenue and Market Share by Countries
8.1.1 South America Traveler's Diarrhea Therapeutics Sales by Countries (2015-2020)
8.1.2 South America Traveler's Diarrhea Therapeutics Revenue by Countries (2015-2020)
8.1.3 Brazil Traveler's Diarrhea Therapeutics Sales and Growth Rate (2015-2020)
8.2 South America Traveler's Diarrhea Therapeutics Revenue (Value) by Manufacturers (2018-2020)
8.3 South America Traveler's Diarrhea Therapeutics Sales, Revenue and Market Share by Type (2015-2020)
8.3.1 South America Traveler's Diarrhea Therapeutics Sales Market Share by Type (2015-2020)
8.3.2 South America Traveler's Diarrhea Therapeutics Revenue and Revenue Share by Type (2015-2020)
8.4 South America Traveler's Diarrhea Therapeutics Sales Market Share by Application (2015-2020)
9 Middle East and Africa Traveler's Diarrhea Therapeutics Market Size Categorized by Countries
9.1 Middle East and Africa Traveler's Diarrhea Therapeutics Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Traveler's Diarrhea Therapeutics Sales by Countries (2015-2020)
9.1.2 Middle East and Africa Traveler's Diarrhea Therapeutics Revenue by Countries (2015-2020)
9.1.3 GCC Countries Traveler's Diarrhea Therapeutics Sales and Growth Rate (2015-2020)
9.1.4 Turkey Traveler's Diarrhea Therapeutics Sales and Growth Rate (2015-2020)
9.1.5 Egypt Traveler's Diarrhea Therapeutics Sales and Growth Rate (2015-2020)
9.1.6 South Africa Traveler's Diarrhea Therapeutics Sales and Growth Rate (2015-2020)
9.2 Middle East and Africa Traveler's Diarrhea Therapeutics Revenue (Value) by Manufacturers (2018-2020)
9.3 Middle East and Africa Traveler's Diarrhea Therapeutics Sales, Revenue and Market Share by Type
9.3.1 Middle East and Africa Traveler's Diarrhea Therapeutics Sales Market Share by Type (2015-2020)
9.3.2 Middle East and Africa Traveler's Diarrhea Therapeutics Revenue and Revenue Share by Type (2015-2020)
9.4 Middle East and Africa Traveler's Diarrhea Therapeutics Sales Market Share by Application (2015-2020)
10 Global Traveler's Diarrhea Therapeutics Market Segment by Type
10.1 Global Traveler's Diarrhea Therapeutics Revenue, Sales and Market Share by Type (2015-2020)
10.1.1 Global Traveler's Diarrhea Therapeutics Sales and Market Share by Type (2015-2020)
10.1.2 Global Traveler's Diarrhea Therapeutics Revenue and Market Share by Type (2015-2020)
10.2 Anti-Motility Agents Sales Growth Rate and Price
10.2.1 Global Anti-Motility Agents Sales Growth Rate (2015-2020)
10.2.2 Global Anti-Motility Agents Price (2015-2020)
10.3 Bismuth Subsalicylate (Pepto-Bismol) Sales Growth Rate and Price
10.3.1 Global Bismuth Subsalicylate (Pepto-Bismol) Sales Growth Rate (2015-2020)
10.3.2 Global Bismuth Subsalicylate (Pepto-Bismol) Price (2015-2020)
10.4 Antibiotics Sales Growth Rate and Price
10.4.1 Global Antibiotics Sales Growth Rate (2015-2020)
10.4.2 Global Antibiotics Price (2015-2020)
11.1 Global Traveler's Diarrhea TherapeuticsSales Market Share by Application (2015-2020)
11.2 Adult Traveler's Diarrhea Sales Growth Rate (2015-2020)
11.3 Children Traveler's Diarrhea Sales Growth Rate (2015-2020)
12.1 Global Traveler's Diarrhea Therapeutics Revenue, Sales and Growth Rate (2020-2027)
12.2 Traveler's Diarrhea Therapeutics Market Forecast by Regions (2020-2027)
12.2.1 Europe Traveler's Diarrhea Therapeutics Market Forecast (2020-2027)
12.2.2 APAC Traveler's Diarrhea Therapeutics Market Forecast (2020-2027)
12.2.3 North America Traveler's Diarrhea Therapeutics Market Forecast (2020-2027)
12.2.4 South America Traveler's Diarrhea Therapeutics Market Forecast (2020-2027)
12.2.5 Middle East & Africa Traveler's Diarrhea Therapeutics Market Forecast (2020-2027)
12.3 Traveler's Diarrhea Therapeutics Market Forecast by Type (2020-2027)
12.3.1 Global Traveler's Diarrhea Therapeutics Sales Forecast by Type (2020-2027)
12.3.2 Global Traveler's Diarrhea Therapeutics Market Share Forecast by Type (2020-2027)
12.4 Traveler's Diarrhea Therapeutics Market Forecast by Application (2020-2027)
12.4.1 Global Traveler's Diarrhea Therapeutics Sales Forecast by Application (2020-2027)
12.4.2 Global Traveler's Diarrhea Therapeutics Market Share Forecast by Application (2020-2027)
13 Analysis of Traveler's Diarrhea Therapeutics Industry Key Manufacturers
13.1 GSK
13.1.1 Company Details
13.1.2 Product Information
13.1.3 GSK Traveler's Diarrhea Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.1.4 Main Business Overview
13.1.5 GSK News
13.2 Salix Pharmaceuticals
13.2.1 Company Details
13.2.2 Product Information
13.2.3 Salix Pharmaceuticals Traveler's Diarrhea Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.2.4 Main Business Overview
13.2.5 Salix Pharmaceuticals News
13.3 Chiesi Farmaceutici
13.3.1 Company Details
13.3.2 Product Information
13.3.3 Chiesi Farmaceutici Traveler's Diarrhea Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.3.4 Main Business Overview
13.3.5 Chiesi Farmaceutici News
13.4 Cosmo Pharmaceuticals
13.4.1 Company Details
13.4.2 Product Information
13.4.3 Cosmo Pharmaceuticals Traveler's Diarrhea Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.4.4 Main Business Overview
13.4.5 Cosmo Pharmaceuticals News
13.5 Nippon Shinyaku
13.5.1 Company Details
13.5.2 Product Information
13.5.3 Nippon Shinyaku Traveler's Diarrhea Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.5.4 Main Business Overview
13.5.5 Nippon Shinyaku News
13.6 Prokarium Limited
13.6.1 Company Details
13.6.2 Product Information
13.6.3 Prokarium Limited Traveler's Diarrhea Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.6.4 Main Business Overview
13.6.5 Prokarium Limited News
13.7 Scandinavian Biopharma
13.7.1 Company Details
13.7.2 Product Information
13.7.3 Scandinavian Biopharma Traveler's Diarrhea Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.7.4 Main Business Overview
13.7.5 Scandinavian Biopharma News
13.8 Sigmoid Pharma
13.8.1 Company Details
13.8.2 Product Information
13.8.3 Sigmoid Pharma Traveler's Diarrhea Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.8.4 Main Business Overview
13.8.5 Sigmoid Pharma News
15 Appendix